2023 – Page 28 – Retraction Watch

‘Kafkaesque nightmare’: Judge wants researcher reinstated as NIH grant PI after med school’s misconduct finding

A federal judge has denied a request for a preliminary injunction by a breast cancer researcher at SUNY Downstate in Brooklyn who sued the university last year after an institutional investigation determined that she committed research misconduct.

However, the judge noted “troubling aspects of this case that bear on serious public health concerns” – namely the discontinuation of the scientist’s research – and also expressed concern about SUNY Downstate and the NIH’s treatment of her.

As we’ve previously reported, Stacy Blain, an associate professor of pediatrics and cell biology at SUNY Downstate, has alleged the university discriminated against her for decades because of her sex, and that the investigation’s finding of misconduct was the result of retaliation after she complained of the discrimination.

Publisher investigating “serious concerns” about article on ivermectin, COVID, and the microbiome

The publisher Frontiers has published an expression of concern for an article that proposed “ivermectin protects against COVID-19” via effects on the microbiome.

The article, “Microbiome-Based Hypothesis on Ivermectin’s Mechanism in COVID-19: Ivermectin Feeds Bifidobacteria to Boost Immunity,” was published in July 2022 in Frontiers in Microbiology. The sole author, Sabine Hazan, is affiliated with ProgenaBiome, a company based in Ventura, Calif. that “spearheads the movement of validating, verifying, and clinically applying its sequencing data, to better understand the microbiome.”

The abstract of the article stated:

J&J subsidiary alleges fraud in paper that linked cosmetic talc with mesothelioma

A key paper linking use of talc-based baby powder to cancer contains fraudulent information, according to a new complaint against an author of the article who has testified on behalf of plaintiffs.

A judge had previously allowed the release of a document confirming the identity of one of the patients in the article, who had claimed exposure to asbestos besides in baby powder, contrary to the authors’ claim that the cases in the series had no other exposures.

The paper, “Mesothelioma Associated With the Use of Cosmetic Talc,” was published in the Journal of Occupational and Environmental Medicine in January 2020. It has been cited 22 times, according to Clarivate’s Web of Science. Corresponding author Jacqueline Moline of Northwell Health in Great Neck, N.Y., has also referenced the article in expert testimony for plaintiffs in talc litigation, as well as in remarks before Congress.

Springer Nature retracts chapter on sign language deaf scholars called “extremely offensive”

Springer Nature has retracted a book chapter which critics say was plagued with “extremely offensive and outdated” statements about the deaf community.

The chapter, “Literature Review on Sign Language Generation,” was published in September 2022 as part of Data Management, Analytics and Innovation: Proceedings of ICDMAI 2022 (International Conference on Data Management, Analytics and Innovation). The authors, five researchers at the Cummins College of Engineering for Women in Pune, India, attempted to review work on sign language translation – specifically with artificial intelligence and machine learning.

From the abstract:

Weekend reads: ‘Breakthroughs’ slowing down?; self-publishing among editors; data tampering in space science

Would you consider a donation to support Weekend Reads, and our daily work?

The week at Retraction Watch featured:

Our list of retracted or withdrawn COVID-19 papers is up to 286. There are more than 38,000 retractions in our database — which powers retraction alerts in EndNote, LibKey, Papers, and Zotero. And have you seen our leaderboard of authors with the most retractions lately — or our list of top 10 most highly cited retracted papers?

Here’s what was happening elsewhere (some of these items may be paywalled, metered access, or require free registration to read):

Urologist blames Big Pharma as concerns mount over his research

With retractions piling up and more than a dozen expressions of concern now added to the list of his publishing woes, a urologist in Iran claims his research is being targeted by American drugmaker Johnson & Johnson.

Mohammad Reza Safarinejad, who offered no evidence for his allegations, says he retired from academia about 10 years ago and now runs a private clinic in Tehran. He has published scores of studies on topics ranging from treatments for premature ejaculation to saffron’s effect on semen, some of which have garnered hundreds of citations.

Starting in 2011, however, journals began pulling his papers over such issues as failure to verify data and inappropriate statistical analyses. The latest retraction, from August 2022, brings the tally up to 15, according to the Retraction Watch Database. And on January 10, The Journal of Urology issued expressions of concern for 14 of his papers, which have been cited a total of nearly 800 times, according to Clarivate’s Web of Science.

The journal states:

Influential paper linking recessions and left-wing voting patterns retracted

A highly cited economics paper that suggested people raised during recessions were more likely to vote for left-leaning political parties has been retracted, apparently due to a coding error that rendered the results invalid.

The retraction marks a rarity among economics papers, which research has shown are infrequently retracted compared to papers on other subjects. The article appears to be the first in The Review of Economic Studies to have been retracted for a reason other than publisher error.

The study’s authors, Paola Giuliano and Antonio Spilimbergo, are economists at the Anderson School of Management at the University of California, Los Angeles and the International Monetary Fund, respectively. Giuliano is also the Chauncey J. Medberry Chair in Management at UCLA.

The paper, “Growing up in a Recession,” was published in November 2013. It has been cited 222 times, according to Clarivate’s Web of Science. Working papers from the World Bank and the Organisation for Economic Co-operation and Development have also cited the article.

Ob-gyn who called criticism ‘racist’ and ‘hate speech’ earns retraction, several expressions of concern

There shouldn’t have been many differences between the women recruited for the three clinical trials: All of them gave birth at the same two Cairo hospitals over a period of less than three years, and all of them were treated to prevent or manage postpartum bleeding. Three samples from this pool of patients, Ben Mol felt, should have had largely similar baseline characteristics.

Yet, mysteriously, the women’s mean age and BMI varied markedly across the studies—from 25 to 34 years and from 25 to 29 kg/m2, respectively—as did the birthweight of their babies.

So the researcher turned data sleuth began digging. His worries only grew. Eventually, he would come to question the integrity of nearly two dozen randomized controlled trials led by Ahmed Maged, a professor of obstetrics and gynecology at Egypt’s top medical school, Kasr AlAiny at Cairo University.

Now, based in part on Mol’s findings, two journals published by Taylor & Francis have issued a retraction and nine expressions of concern for the following papers:

Reddit post prompts retraction of article that called Trump ‘the main driver of vaccine misinformation on Twitter’

In October 2021, a Reddit user on the r/badscience subforum posted a long critique of an article published in PLOS ONE earlier that year that had analyzed the “anti-vaccination infodemic” on Twitter and concluded that former U.S. president Donald Trump was “the main driver of vaccine misinformation” on the platform before his account was suspended.

The critique, titled “Terrible PlosOne Paper Dissected,” listed concerns about the sample size (50 pro-vaccine and 50 anti-vaccine accounts), method of selecting the sample and control groups, and data analysis. The Redditor also looked at the reviews of the article which PLOS ONE made available, and concluded that “clearly neither reviewer actually read it in any detail.”

The day after the comment was posted, an account for PLOS Communications responded, thanking the user “for your post publication peer review” and saying that PLOS ONE was looking into the article.

Weekend reads: ChatGPT fools scientists; did COVID-19 trials cut corners?; do scientific societies need journals?

Would you consider a donation to support Weekend Reads, and our daily work?

The week at Retraction Watch featured:

Our list of retracted or withdrawn COVID-19 papers is up to 285. There are more than 38,000 retractions in our database — which powers retraction alerts in EndNote, LibKey, Papers, and Zotero. And have you seen our leaderboard of authors with the most retractions lately — or our list of top 10 most highly cited retracted papers?

Here’s what was happening elsewhere (some of these items may be paywalled, metered access, or require free registration to read):

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this: